Pharmaron Beijing Co Ltd Cash Flow-to-Debt Ratio
Pharmaron Beijing Co Ltd cash flow-to-debt ratio. Pharmaron Beijing Co Ltd (300759) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥1.04 Billion could theoretically repay 0% of its total liabilities (CN¥10.62 Billion) in one year. Check 300759 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pharmaron Beijing Co Ltd (2014–2024)
Cash flow-to-debt ratio of Pharmaron Beijing Co Ltd from 2014 to 2024. Historical debt coverage capacity for Pharmaron Beijing Co Ltd across 11 annual periods. Check Pharmaron Beijing Co Ltd (300759) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Pharmaron Beijing Co Ltd Cash Flow-to-Debt Ratio by Year (2014–2024)
Pharmaron Beijing Co Ltd cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for Pharmaron Beijing Co Ltd. For the full cash flow conversion analysis, see Pharmaron Beijing Co Ltd (300759) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥2.58 Billion | CN¥9.70 Billion | ▲ +27.7% |
| 2023 | 0.21x | CN¥2.75 Billion | CN¥13.24 Billion | ▼ -6.3% |
| 2022 | 0.22x | CN¥2.14 Billion | CN¥9.65 Billion | ▼ -12.7% |
| 2021 | 0.25x | CN¥2.06 Billion | CN¥8.09 Billion | ▼ -54.1% |
| 2020 | 0.55x | CN¥1.65 Billion | CN¥2.98 Billion | ▲ +23.8% |
| 2019 | 0.45x | CN¥938.59 Million | CN¥2.10 Billion | ▲ +38.6% |
| 2018 | 0.32x | CN¥737.26 Million | CN¥2.28 Billion | ▲ +11.6% |
| 2017 | 0.29x | CN¥552.22 Million | CN¥1.91 Billion | ▲ +27.7% |
| 2016 | 0.23x | CN¥235.77 Million | CN¥1.04 Billion | ▲ +5.0% |
| 2015 | 0.22x | CN¥216.94 Million | CN¥1.01 Billion | ▲ +1096.2% |
| 2014 | 0.02x | CN¥12.13 Million | CN¥673.22 Million | — |